| abstract |
The present application provides sulphonamide derivatives of the formula: R?1-O-CR5R6-CH¿2-NHSO2-R2, in which the variables are as defined in the claims, useful for potentiating glutamate receptor function in a patient and therefore useful for improving memory and learning ability and for treating depression, Alzheimer's disease, psychosis and cognitive defects associated with psychosis. |